4-Methylimidazole Risks on Our Life

Mostafa Norizadeh Tazehkand*

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Bulent Ecevit University, Zonguldak, Turkey.

Corresponding Author:
Mostafa Norizadeh Tazehkand
Tel: +90 5372891027
E-mail: [email protected]

Received date: January 30, 2018; Accepted date: February 12, 2018; Published date: February 20, 2018

Citation: Tazehkand MN. 4-Methylimidazole Risks on Our Life. Electronic J Biol, 14:1

Visit for more related articles at Electronic Journal of Biology


Caramel colors of foods have been grouped in 4 classes by the Joint FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization) Expert Committee on Food Additives (JECFA), and the European Union Scientifi c Committee for Food [1]. 4-Methylimidazole (4-MI) (a heterocyclic organic chemical compound) is subjected to unavoidable formation during cooking in some foods and beverages, including coffee, beers, soy sauces. Some of these soft drinks which use caramel coloring will contain 4-MEI [2]. 4-MEI (4-Methylimidazole) is light yellow, 4-MEI is used as a chemical intermediate in the manufacture of photographic chemicals, dyes and some pigments and some rubbers. 4-MEI is formed as a result of the interaction of ammonia with reducing sugars [1]. It will be used as byproduct in some foods and beverages during some of cooking process associated with heat and browning. For example cola drinks may contain more than 100 μg of this compound per 12 ounce serving [3,4].

The toxicity of 4-MEI has been reported in many International agencies including the National Toxicology Program [4] and many articles. In 2007, NTP reported “clear evidence of carcinogenic activity” of 4-MEI in animal studies, based on increased incidences of alveolar/bronchiolar neoplasms [5].

The National Toxicology Program (NTP) conducted a two year feeding cancer bioassay of 4-MEI in mice and rats. In F344/N rat’s ambiguous evidence of carcinogenic activity in female rats based on incidences of mononuclear cell leukemia and no evidence of carcinogenic activity in male rats were observed [6]. Chromosome aberration (CA) assay is one of methods to measure cytotoxicity and genotoxicity [7]. In 2015, Tazehkand et al. [8] reported that 4-MEI might not anti-genotoxic and protective effects in bone marrow cells of Swiss Albino Mice, because 4-MEI could not reduce the chromosomal aberrations induced by EMS. In 2016, Tazehkand et al. [9] reported that 4-MEI induced structural CAs at all concentrations for 12 h and at highest concentration for 24 h treatment periods and decreased the MI at highest concentration for 12 h and at all concentrations for 24 h in bone marrow cells of Swiss Albino mice. This result showed that 4-MEI has cytotoxic and genotoxic effect in bone marrow cells of Swiss Albino mice [9]. At another research from same researchers 4-MEI has cytotoxic effect on 3T3-L1 and colon cancer cell lines and has necrotic effect on rat liver cells [10,11].

MacKenzie et al. [12] observed that female and male rats given caramel color IV (110 mg 4MEI/kg body weight) in drinking water at concentration of 10 g/kg for 2 years had significantly lower body weights, but not observed any histopathological changes [12]. In another study, Bu et al. [13] reported that 4-MEI at lower concentrations (≤ 100 μg/ml) has no significant effect on the biological characteristics, including proliferation, apoptosis, migration and genes of hematogenesis expression and differentiation of BMSCs. Therefore, relatively low concentration of 4-MI in foods and beverages may have no toxic effect on BMSCs [13].

Therefore, it can be concluded that 4-MEI might pose a potential risk for humans. However, it must be investigated in other test systems for genotoxic and cytotoxic effects.


Select your language of interest to view the total content in your interested language

Viewing options

Post your comment

Share This Article

Recommended Conferences

  • 6th Annual Congress on Biology and Medicine of MoleculesSeptember 20-21, Kuala Lumpur, Malaysia
  • 13th International Conference on Biologics and BiosimilarsOctober 24-25, Boston, USA
Flyer image
journal indexing image

Post your comment

captcha   Reload  Can't read the image? click here to refresh